Skip to content

EQA Program

Our external quality assessment (EQA) program is aimed at medical laboratories and point-of-care testing sites. The program includes more than 250 clinically relevant external quality assessment schemes and it is compliant with ISO 15189 standard requirements.

Changes in the 2024 program

New schemes and products

  • 2707 Maternal serum screening
  • 8205 Pipette control
  • 5254 Mycoplasma genitalium, drug resistance, nucleic acid detection
  • 5253 Helicobacter pylori, nucleic acid detection
  • 5088 HIV, antibodies and antigen detection, extra set of samples
  • 5231 Mycobacterium tuberculosis, drug resistance, nucleic acid detection, extra set of samples
  • 4389 D-dimer, extra set of samples
  • 5683 Mpox (Monkeypox virus), nucleic acid detection
  • 8850 DNA sequencing (EQUALIS)
  • 8851 Quantification of ABO antibodies (EQUALIS)
  • 8852 Titration of erythrocyte antibodies (EQUALIS)
  • 8853 Iohexol (EQUALIS)
  • 8854 Phosphatidyl ethanol in blood (EQUALIS)
  • 8855 Alcohol biomarkers in urine (EQUALIS)

Planned pilot schemes

Pilot schemes are EQA schemes under our product development.

All changes are listed in the Product Catalogue 2024 on page 5.

LQ_web news_EQA program 2024_1280x720


Subscription for 2024 will open on 2 October 2023

Please subscribe to the 2024 EQA programs before the end of November 2023 to ensure your participation in all needed EQA rounds. You can renew your subscription by contacting our local partner in your country. Direct customers of Labquality can renew their subscriptions on LabScala starting on 2 October 2023. If you need more information, please contact our customer service:

Sales and Customer Service

Juha Wahlstedt
Juha Wahlstedt
EQA Sales Director
+358 50 327 5338
Jukka Korhonen
Jukka Korhonen
Key Account Manager
+358 50 540 9351
Minna Kankainen
Minna Kankainen
Customer Service Manager
+358 45 131 1682

Related Services

Latest news

12/06/24 08:44

Clinical investigations of medical devices: What's new in 2024?

MDR regulation changes 2024. Free short course: Clinical investigations regulations and trends
Read more
03/06/24 13:00

Labquality strengthens its regulatory affairs service capabilities and expands to Sweden

Labquality, supported by Mérieux Equity Partners, acquires QAdvis AB.
Read more
25/04/24 17:11

Meet us at RAPS in Berlin on May 6-8!

Visit our booth TB1 in the RAPS exhibition and hear about regulatory affairs services for and MD/IVD manufacturers.
Read more
05/04/24 15:04

Meet us in Tomar, Portugal

Labquality will attend SPML's (Sociedade Portuguesa de Medicina Laboratorial) 16th scientific meeting in Tomar, Portugal, from 12 to 13 April 2024.
Read more
25/03/24 11:10

Meet us at ECCMID in Barcelona

Visit our booth E5 in the ECCMID exhibition and hear about EQA services for microbiology, as well as CRO services for pharmaceuticals and MD/IVD manufacturers.
Read more

Subscribe to our newsletter

Subscribe to hear the latest news in the industry and keep track of what's happening behind the scenes.